Assessment of the Effectiveness of Menopur in Intrauterine Insemination

Assessment of the Clinical Efficacy of Menopur® in Intrauterine Artificial Insemination (From Partner or From Donor)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01354834

Enrollment

207

Registered

2011-05-17

Start date

2004-03-31

Completion date

2006-04-30

Last updated

2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

The purpose of this study is to assess the effectiveness of Menopur to achieve clinical pregnancy in females undergoing intrauterine insemination in clinical practice.

Interventions

DRUGhMG

Patients with a condition

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Infertile couples for over one year (primary or secondary) or infertile women (or not) with indication of PAI or DAI * Seminal sample suitable for artificial insemination treatment according to the criterion of each centre * Patient prescribed therapy with Menopur in artificial insemination

Exclusion criteria

* Contraindications to intrauterine insemination * Contraindications to Menopur

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate	30 days

Secondary

Measure	Time frame
Live birth rate	40 weeks

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026